Wall St set for $1bn fee bonanza from pharma mega-deal

Bristol-Myers Squibb and Celgene $90bn merger ranks among most lucrative for banks
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news